V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10005857 | 10003716 | 1.52 | 84.2 | Adjuvant (A) | 2017-06-27 | 2017-09-06 | Irinotecan + Modified De Gramont | 02 | N | 10286545 | IRINOTECAN + MDG |
| 10005858 | 10003719 | 1.65 | 0 | Palliative (P) | 2015-02-04 | 2015-02-11 | Rituximab | N | N | 10287071 | RITUXIMAB |
| 10005859 | 10003719 | 1.58 | 72 | Adjuvant (A) | 2017-03-20 | 2017-08-03 | PEMBROLIZUMAB | N | N | 10287071 | PEMBROLIZUMAB |
| 10005860 | 10003720 | 1.77 | 130 | Palliative (P) | 2014-09-05 | 2014-09-12 | Docetaxel | N | N | 10287391 | DOCETAXEL |
| 10005861 | 10003721 | null | 71.4 | Palliative (P) | null | 2016-07-25 | TRASTUZUMAB | 2 | Y | 10287556 | TRASTUZUMAB |
| 10005862 | 10003721 | 1.75 | 60.75 | Adjuvant (A) | 2018-08-02 | 2018-08-18 | Irinotecan + Modified De Gramont | N | N | 10287556 | IRINOTECAN + MDG |
| 10005863 | 10003722 | 1.68 | 69.4 | Adjuvant (A) | 2019-03-03 | 2019-03-03 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10287740 | PACLITAXEL |
| 10005864 | 10003722 | 1.65 | 88.1 | Palliative (P) | 2017-11-08 | 2017-11-08 | TRASTUZUMAB | N | N | 10287740 | TRASTUZUMAB |
| 10005865 | 10003724 | 1.78 | 96.95 | Adjuvant (A) | null | 2017-08-14 | PEMBROLIZUMAB | N | N | 10288050 | PEMBROLIZUMAB |
| 10005866 | 10003724 | 1.53 | 49.45 | Palliative (P) | 2013-07-02 | 2013-07-13 | PACLITAXEL | N | N | 10288050 | PACLITAXEL |
| 10005867 | 10003725 | 1.64 | 70.9 | Curative (C) | 2019-02-13 | 2019-02-25 | CHOP R - 21 days | 02 | N | 10288769 | CHOP R |
| 10005868 | 10007003 | 1.56 | 79.9 | Palliative (P) | null | 2018-06-28 | Irinotecan + Modified De Gramont | N | N | 10288787 | IRINOTECAN + MDG |
| 10005869 | 10007003 | 1.7 | 104 | Palliative (P) | 2017-12-27 | 2017-12-28 | CAPECITABINE + OXALIPLATIN | N | N | 10288787 | CAPECITABINE + OXALIPLATIN |
| 10005870 | 10003726 | 1.76 | null | Adjuvant (A) | 2015-10-17 | 2016-01-03 | PACLITAXEL | 2 | N | 10288922 | PACLITAXEL |
| 10005871 | 10003726 | 1.9 | 71 | Adjuvant (A) | 2016-08-18 | 2016-09-05 | TRASTUZUMAB | N | N | 10288922 | TRASTUZUMAB |
| 10005872 | 10003727 | 1.82 | 97.8 | Curative (C) | 2018-11-27 | 2019-02-16 | PEMBROLIZUMAB | 02 | null | 10289319 | PEMBROLIZUMAB |
| 10005873 | 10003728 | 1.78 | 78.9 | null | null | 2016-09-23 | CHOP R | null | N | 10290058 | CHOP R |
| 10005874 | 10003729 | 1.77 | 72.4 | Adjuvant (A) | 2016-11-03 | 2016-11-11 | FLUOROURACIL + IRINOTECAN | N | N | 10290060 | IRINOTECAN + MDG |
| 10005875 | 10003730 | 1.68 | 83 | Disease modification (D) | 2015-05-26 | 2015-07-29 | Rituximab (Maintenance) | 02 | N | 10290114 | RITUXIMAB |
| 10005876 | 10003731 | 1.88 | 84 | Adjuvant (A) | 2017-04-13 | 2017-07-06 | CAPECITABINE + OXALIPLATIN | N | N | 10290454 | CAPECITABINE + OXALIPLATIN |
| 10005877 | 10003732 | null | null | Adjuvant (A) | 2017-12-08 | 2017-12-08 | Rituximab (Maintenance) | 02 | null | 10290463 | RITUXIMAB |
| 10005878 | 10003734 | null | 87 | Neo-adjuvant (N) | 2015-11-11 | 2016-02-28 | Rituximab | N | N | 10290720 | RITUXIMAB |
| 10005879 | 10003735 | null | 71.2 | Adjuvant (A) | 2015-09-13 | 2016-05-17 | FLUOROURACIL + OXALIPLATIN | N | N | 10290800 | OXALIPLATIN + MDG |
| 10005880 | 10003736 | null | 71.2 | Palliative (P) | 2017-03-25 | 2017-04-16 | Rituximab | null | null | 10290800 | RITUXIMAB |
| 10005881 | 10003737 | 1.53 | 45.95 | Palliative (P) | 2018-05-22 | 2018-07-09 | Oxaliplatin + Modified de Gramont | N | N | 10290885 | OXALIPLATIN + MDG |
| 10005882 | 10003738 | 1.67 | 90.6 | Palliative (P) | 2018-01-29 | 2018-01-31 | PEMBROLIZUMAB | 2 | N | 10291209 | PEMBROLIZUMAB |
| 10005883 | 10003738 | 1.59 | 55.9 | Adjuvant (A) | null | 2018-01-04 | Docetaxel 75mg/m2 (21 day) | N | N | 10291209 | DOCETAXEL |
| 10005884 | 10003739 | 1.87 | 75.199 | Palliative (P) | null | 2015-05-07 | Irinotecan + Modified De Gramont | N | N | 10291536 | IRINOTECAN + MDG |
| 10005885 | 10003740 | 1.63 | 66 | Curative (C) | 2018-02-22 | 2018-03-16 | Oxaliplatin + Modified de Gramont | 02 | null | 10291542 | OXALIPLATIN + MDG |
| 10005886 | 10003740 | 1.66 | 79.5 | Palliative (P) | null | 2018-03-05 | PEMBROLIZUMAB | N | N | 10291542 | PEMBROLIZUMAB |
| 10005887 | 10003740 | 1.61 | 63.5 | Adjuvant (A) | null | 2018-11-10 | Paclitaxel 7 day | N | N | 10291542 | PACLITAXEL |
| 10005888 | 10009241 | 1.68 | 90.1 | Curative (C) | 2017-08-23 | 2017-12-09 | Oxaliplatin + Modified de Gramont | N | N | 10292517 | OXALIPLATIN + MDG |
| 10005889 | 10003741 | 1.53 | 84.3 | Disease modification (D) | 2017-02-20 | 2017-06-16 | CAPECITABINE + OXALIPLATIN | 02 | N | 10292554 | CAPECITABINE + OXALIPLATIN |
| 10005890 | 10003745 | 1.83 | 87.6 | Not known (9) | 2016-08-20 | 2016-08-25 | Trastuzumab Subcutaneous | N | N | 10292573 | TRASTUZUMAB |
| 10005891 | 10003746 | 1.56 | 64.2 | Adjuvant (A) | 2018-02-05 | 2018-02-08 | Docetaxel | 02 | N | 10292573 | DOCETAXEL |
| 10005892 | 10003746 | null | null | Adjuvant (A) | 2015-06-24 | 2015-06-29 | Trastuzumab Subcutaneous | 2 | N | 10292573 | TRASTUZUMAB |
| 10005893 | 10003746 | 1.68 | 69.8 | Adjuvant (A) | null | 2018-02-21 | Rituximab | N | null | 10292573 | RITUXIMAB |
| 10005894 | 10003747 | 1.7 | 84 | Adjuvant (A) | null | 2016-05-25 | CHOP R | N | N | 10292997 | CHOP R |
| 10005895 | 10003747 | 1.72 | 89 | Palliative (P) | null | 2018-02-24 | CHOP R - 21 days | 2 | N | 10292997 | CHOP R |
| 10005896 | 10003747 | 1.75 | 80.3 | Adjuvant (A) | 2018-09-08 | 2018-12-01 | Capecitabine + Oxaliplatin 14day | N | N | 10292997 | CAPECITABINE + OXALIPLATIN |
| 10005897 | 10008905 | 0 | 94.15 | Palliative (P) | 2018-04-28 | 2018-05-03 | Docetaxel 75mg/m2 (21 day) | 02 | null | 10293594 | DOCETAXEL |
| 10005898 | 10008905 | 1.77 | 75 | Adjuvant (A) | 2019-02-08 | 2019-02-16 | DOCETAXEL + Prednisolone | N | N | 10293594 | DOCETAXEL |
| 10005899 | 10008905 | 1.79 | 52.5 | Palliative (P) | null | 2017-03-30 | TRASTUZUMAB | N | N | 10293594 | TRASTUZUMAB |
| 10005901 | 10003749 | 1.61 | 61.85 | Palliative (P) | 2017-09-09 | 2017-09-16 | Trastuzumab Subcutaneous | N | N | 10294487 | TRASTUZUMAB |
| 10005902 | 10003750 | 1.81 | 82.2 | Palliative (P) | 2017-05-12 | 2017-06-06 | PACLITAXEL | 2 | N | 10294576 | PACLITAXEL |
| 10005903 | 10003750 | 1.8 | 72 | Palliative (P) | 2017-10-07 | 2017-12-02 | Irinotecan + Modified De Gramont | 02 | N | 10294576 | IRINOTECAN + MDG |
| 10005904 | 10003752 | 1.79 | 96.8 | Adjuvant (A) | 2015-08-27 | 2015-09-11 | CHOP R - 21 days | 2 | N | 10294778 | CHOP R |
| 10005905 | 10003753 | 1.77 | null | Palliative (P) | 2016-04-16 | 2016-07-04 | CHOP R - 21 days | N | N | 10294849 | CHOP R |
| 10005906 | 10003755 | 1.6 | 85.1 | Disease modification (D) | 2016-01-02 | 2016-01-29 | PEMBROLIZUMAB | N | N | 10294898 | PEMBROLIZUMAB |
| 10005907 | 10003756 | 1.67 | 0 | Adjuvant (A) | 2015-03-13 | 2015-04-23 | Rituximab | N | N | 10295022 | RITUXIMAB |